Docetaxel weekly regimen in conjunction with RF hyperthermia for pretreated locally advanced non-small cell lung cancer: a preliminary study

Docetaxel weekly regimen in conjunction with RF hyperthermia for pretreated locally advanced non-small cell lung cancer: a preliminary study

<p>Abstract</p> <p>Background</p> <p>To evaluate the feasibility and therapeutic effect of chemotherapy combined with regional radio frequency hyperthermia for pretreated locally advanced non-small cell lung cancer.</p> <p>Methods</p> <p>29 patie...

Full description

Bibliographic Details
Main Authors:	Ming Jiang, Yan Wang, Jiang Zhu, Yu Yang
Format:	Article
Language:	English
Published:	BMC 2007-10-01
Series:	BMC Cancer
Online Access:	http://www.biomedcentral.com/1471-2407/7/189

Similar Items

A comparative clinical study of weekly regimen of docetaxel compared with that of 3-weekly regimen in the treatment of patients with advanced non-small cell lung cancer
by: Hongjian XUE, et al.
Published: (2008-06-01)

A pilot study of a metronomic chemotherapy regimen with weekly low-dose docetaxel for previously treated non-small cell lung cancer
by: Yokoi T, et al.
Published: (2012-05-01)

Retrospective Study of Weekly Docetaxel (Taxotere) in Previously Treated Non-Small Cell Lung Cancer
by: Yin Lo, et al.
Published: (2004)

SINGLE AGENT DOCETAXEL AS SECOND- LINE CHEMOTHERAPY FOR PRETREATED PATIENTS WITH RECURRENT NON- SMALL CELL LUNG CANCER
by: Deyan N. Davidov
Published: (2013-04-01)

Concurrent chemoradiotherapy with low-dose weekly docetaxel followed by consolidation chemotherapy with docetaxel and cisplatin in the treatment of stage III non-small cell lung cancer
by: Tianlin XIAO, et al.
Published: (2008-02-01)

Efficacy and safety of PD1/PDL1 blockades versus docetaxel in patients with pretreated advanced non-small-cell lung cancer: a meta-analysis
by: Liu J, et al.
Published: (2018-12-01)

A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer
by: Junwen Ou, et al.
Published: (2020-07-01)

The combination therapy of hyperthermia and chemotherapy regimens for the treatment of non-small cell lung cancer: A meta-analysis
by: Di Han, et al.
Published: (2020-07-01)

BSD2000 Deep Hyperthermia Combined with Chemotherapy of PT regimen in Patients with Non-small Cell Lung Cancer
by: Yanwen WANG, et al.
Published: (2010-02-01)

RF/microwave absorbing nanoparticles and hyperthermia
by: Cook, Jason Ray
Published: (2010)

Feasibility study of docetaxel, oxaliplatin and capecitabine combination regimen in advanced gastric or gastroesophageal adenocarcinoma
by: Gaurav Goel, et al.
Published: (2010-04-01)

Study on Energy Distribution of RF Hyperthermia System
by: Wu,Yu Ling, et al.
Published: (1993)

Duration of nivolumab for pretreated, advanced non–small‐cell lung cancer
by: Margaux Geier, et al.
Published: (2020-10-01)

Radiofrequency deep hyperthermia combined with chemotherapy in the treatment of advanced non-small cell lung cancer
by: Wen-Hui Yang, et al.
Published: (2019-04-01)

The efficacy and safety of ramucirumab plus docetaxel in older patients with advanced non‐small cell lung cancer
by: Tadashi Sakaguchi, et al.
Published: (2020-06-01)

A Retrospective Cohort Study on Pretreated Neutrophil-to-Lymphocyte Ratio and Prognosis of Small Cell Lung Cancer: Evidence of Effect Modification by Chemotherapy Regimen
by: Liu F, et al.
Published: (2020-10-01)

HYPERTHERMIA IN TREATMENT OF NON-SMALL CELL LUNG CANCER
by: А. Yu. Dobrodeev, et al.
Published: (2016-02-01)

Bevacizumab and Weekly Docetaxel in Patients with Metastatic Castrate-Resistant Prostate Cancer Previously Exposed to Docetaxel
by: Filippo Francini, et al.
Published: (2011-01-01)

A Case of Advanced Extramammary Paget's Disease Successfully Controlled by Monthly but Not Weekly Docetaxel Chemotherapy
by: Yuki Yoshihara, et al.
Published: (2016-01-01)

Pemetrexed for Heavily Pretreated Patients With Advanced Non-small Cell Lung Cancer
by: Jih-Hsiang Lee, et al.
Published: (2010-05-01)

Advances in Nanocarriers for Effective Delivery of Docetaxel in the Treatment of Lung Cancer: An Overview
by: S. Aishah A. Razak, et al.
Published: (2021-01-01)

Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study
by: Krittiya Korphaisarn, et al.
Published: (2021-04-01)

Phase I Trial of Weekly Short Infusion of Single Agent Docetaxel in Patients with Advanced NSCLC/MBC
by: Hsing-Ju, Pan, et al.
Published: (2000)

The role of docetaxel in the multimodal treatment of non-small cell lung cancer
by: Rita De Sanctis, et al.
Published: (2009-06-01)

Docetaxel as Salvage Therapy in Highly Pretreated and Drug Resistant Gastrointestinal Carcinomas
by: Martin F. Sprinzl, et al.
Published: (2008-01-01)

Concomitant chemoradiotherapy with docetaxel and cisplatin followed by consolidation chemotherapy in locally advanced unresectable non-small cell lung cancer
by: Celalettin Eroglu, et al.
Published: (2013-01-01)

Weekly docetaxel in an elderly patient with refractory classic Kaposi sarcoma
by: Rongbo Lin
Published: (2016-06-01)

A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer
by: Pavlakou Georgia, et al.
Published: (2010-11-01)

Feasibility and Response of Concurrent Weekly Docetaxel with Radical Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
by: Jomon Raphael C, et al.
Published: (2015-03-01)

Predictive value of pretreatment albumin‐to‐alkaline phosphatase ratio for overall survival for patients with advanced non‐small cell lung cancer
by: Shaozhang Zhou, et al.
Published: (2020-09-01)

Data to establish the optimal standard regimen and predicting the response to docetaxel therapy
by: Emad Y. Moawad
Published: (2015-12-01)

Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?
by: Jie Xu, et al.
Published: (2018-10-01)

The registration of postinstillative hyperthermia in eyes with the help of a thermograph as a means of displaing iatrogenic conjunctivitis
by: M L Kashkovskiy, et al.
Published: (2009-12-01)

Effects of Docetaxel Combined with Icotinib on Serum Tumor Markers and Quality of Life of Patients with Advanced Non-Small Cell Lung Cancer
by: Huawei LIN, et al.
Published: (2020-10-01)

Severe Organizing Pneumonia after Two Cycles of Docetaxel as Fourth-Line Chemotherapy for Advanced Non-Small Cell Carcinoma of the Lung
by: Jens Hasskarl, et al.
Published: (2009-02-01)

A Meta-analysis of Platinum Plus Docetaxel or Vinorelbine in the First-line  Treatment of Advanced Non-small Cell Lung Cancer
by: Taisheng LIU, et al.
Published: (2014-04-01)

Regional hyperthermia combined with chemotherapy in advanced gastric cancer
by: Fang Hongming, et al.
Published: (2019-02-01)

Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapy
by: Kristensen Vessela, et al.
Published: (2007-10-01)

Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung Cancer
by: Koichi Takayama, et al.
Published: (2016-01-01)

Effect of docetaxel + oxaliplatin + S-1 and docetaxel + cisplatin + fluorouracil on treatment of advanced gastric cancer
by: Wei Li, et al.
Published: (2016-09-01)